Blog

In the realm of animal models used for studying infectious diseases, the mouse has established itself as a methodological standard ........ yet, at the heart of these studies, a discreet but powerful molecule can undermine results: ....

Imagine a hidden community, nestled deep within the gut, made up of billions of microorganisms. This vast and invisible population—our microbiota—communicates in a language of chemical signals, metabolites, and subtle ecological balances. And prebiotics?

In recent years, artificial intelligence (AI) has rapidly become a cornerstone of innovation in life sciences. But while headlines often focus on its use in radiology or drug discovery, a quieter revolution is taking place in microbiology — one that may prove just as transformative, particularly for preclinical research in infectious diseases.

Climate change is not only reshaping our environment — it’s also accelerating the spread of infectious diseases, including dangerous fungal pathogens.

While seasonal flu is often spoken of as a single entity, Influenza B tends to remain in the shadow of its cousin, Influenza A — yet its health and economic burden is far from negligible.

Did you know that Influenza B accounts for nearly one-third of seasonal flu cases each year?

Effective management of AMR and CC demands robust economic and political actions. Global and national plans should be aligned to address these interconnected challenges. Policies need to encourage the responsible use of antimicrobials and foster environmental sustainability. 

In the face of escalating antimicrobial resistance (AMR), researchers and innovators are turning to advanced technologies like Artificial Intelligence (AI) and genomic sequencing to pave new roads in the battle against superbugs.

In the wake of the upcoming UN General Assembly, the spotlight turns to a pressing global health challenge: antimicrobial resistance (AMR). 

Escherichia coli, commonly referred to as E. coli, is a familiar term to many. It is a rod-shaped bacterium that is typically found in the lower intestines of warm-blooded organisms, including humans.

Bacteria rely on a system called quorum sensing (QS) to sense population density and make collective decisions.

The 6M € granted to IN-ARMOR project will optimize an already developed drug platform using Computer Aided Drug Design. 

Vibiosphen’s constant objective is to develop innovative and translational experimental models that would ultimately result in the decrease of the number of animals used for preclinical testings.